INCYTE
Manufacturing · Delaware, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1801 Augustine Cut Off, Wilmington, Dela...Phone Number
(302) 498-6700Website
www.incyte.comRevenue
$5.8 BillionStock Symbol
INCYIndustry
About INCYTE
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.Explore more
INCYTE Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to INCYTE
Compare insights from companies similar to INCYTE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$12.6B
5K - 10K
Public
$2.5B
1989
GL
Gina LaCorciaVice President, Chief of Staff To the CEO and Head of the Disease Strategy Team Program Office
$705.2M
1K - 5K
Private
-
1993
RP
Rushi PotdarChief Medical Officer & Head of Global Medical Affairs, Global Oncology Business Unit (Gobu)
$250.8M
501-1,000
Private
-
1991
RK
Robert KuehlExecutive Director, Drug Product Manufacturing & Development
INCYTE Tech Stack
A closer look at the technologies used by INCYTE
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INCYTE
Sign Up For FreeTo access detailed company insights
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome... Read More
